Ion DX, Inc is an innovative life sciences company based in Monterey, CA, with over 40 years of experience in developing analytical instrumentation for biomacromolecules and nanomaterials. Led by a team of key scientists in the Human Genome Project and X-ray Free Electron Laser serial femtosecond crystallography, Ion DX has a strong track record with 100 publications, 8000 citations, and 20 patents. Their expertise in mass spectrometry and bioanalytical thought leadership has been recognized in prestigious scientific journals such as Nature, Science, and PNAS.
Under the leadership of CEO Luis Carbonell, Ion DX has successfully commercialized proprietary technologies, including a lung cancer diagnostic test and a novel nanopipette technology for single cell analysis. With the guidance of Founder and CTO Henry Benner, the company has introduced groundbreaking analytical instruments and methodologies in various fields, including aerosol science, cholesterol testing, and point-of-care diagnostics. Supported by CFO Marilyn J. Thompson and VP of Business and Strategy Ananya Dubey Kelsoe, Ion DX is committed to revolutionizing the life sciences industry through their next-generation equipment, such as their flagship product IMgenius.
Generated from the website